Woo Jennifer S, Tseng Jennifer, Kang Irene M, Zhuang Lefan, Jackson Ryan, Danilova Olga V, Borogovac Azra
Department of Pathology, City of Hope National Medical Center, Irvine, CA.
Department of Surgery, City of Hope National Medical Center, Irvine, CA.
Ochsner J. 2024 Winter;24(4):309-313. doi: 10.31486/toj.24.0046.
Prolongation of the activated partial thromboplastin time (aPTT) may signify an intrinsic factor deficiency or the presence of an inhibitor of coagulation, potentially placing a patient at increased risk for bleeding. However, a contact factor (ie, factor XII, prekallikrein, and high molecular weight kininogen) deficiency, which may also cause a prolonged aPTT, is not associated with clinical bleeding. A 71-year-old female had an isolated prolonged aPTT discovered during preoperative laboratory testing. Results of the initial coagulation tests demonstrated no deficiency of factors VIII, IX, or XI and no evidence for lupus anticoagulant or antiphospholipid antibodies. However, a mixing study test was suggestive of factor deficiency. Based on these results, contact factor activity tests were performed to identify any contact factor deficiency. The patient was determined to have a prekallikrein deficiency. Rare causes of isolated prolonged aPTT include contact factor deficiencies such as prekallikrein deficiency. Identification of a contact factor deficiency is clinically useful information, as it allows for a definitive assessment of bleeding risk. This case reports a rare factor deficiency and illustrates a contemporary approach to the workup of an isolated prolonged aPTT.
活化部分凝血活酶时间(aPTT)延长可能意味着存在内源性凝血因子缺乏或凝血抑制剂,这可能会使患者出血风险增加。然而,接触因子(即因子Ⅻ、前激肽释放酶和高分子量激肽原)缺乏也可能导致aPTT延长,但与临床出血无关。一名71岁女性在术前实验室检查中发现单纯aPTT延长。初始凝血试验结果显示因子Ⅷ、Ⅸ或Ⅺ无缺乏,也没有狼疮抗凝物或抗磷脂抗体的证据。然而,混合试验提示存在因子缺乏。基于这些结果,进行了接触因子活性试验以确定是否存在接触因子缺乏。该患者被确定存在前激肽释放酶缺乏。孤立性aPTT延长的罕见原因包括接触因子缺乏,如前激肽释放酶缺乏。确定接触因子缺乏是具有临床实用价值的信息,因为它有助于明确评估出血风险。本病例报告了一种罕见的因子缺乏,并阐述了对孤立性aPTT延长进行检查的现代方法。